// App-Quantinova.ai

PO1165 : Disease Course of Hyperkalemia in Patients on Hemodialysis

Researchers

Presenter

  • Spinowitz BruceS

Principal Investigators

  • Fishbane Steven

  • Fukagawa Masafumi

  • Ford MartinL

  • Guzman NicolasJose

  • Rastogi Anjay

Medical Centers

  • New York Presbyterian Queens, New York, NY, United States.

  • Zucker School of Medicine at Hofstra/Northwell Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Great Neck New York United States

  • Tokai University School of Medicine, Isehara, Japan

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • AstraZeneca BioPharmaceuticals Research and Development Gaithersburg Maryland United States

  • David Geffen School of Medicine at UCLA, Los Angeles, California, United States

Locations

  • United States

  • Japan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hyperkalemia

Biomarkers

  • N/A

Drug/Treatment

  • Sodium zirconium cyclosilicate

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved